US2005019376A1PendingUtilityA1

Dosage form containing a confectionery composition

48
Priority: Sep 28, 2001Filed: Sep 28, 2002Published: Jan 27, 2005
Est. expirySep 28, 2021(expired)· nominal 20-yr term from priority
Inventors:Gerard P. McnallyFrank J. BunickHarry S. SowdenGus LabellaTimothy GilmorDer-Yang LeeMartin Thomas
A61P 29/00A23G 3/04A61K 9/2893A61K 9/2853A23G 3/368B30B 11/08B30B 11/34A61P 29/02A61K 9/2873A61J 3/10A61J 3/005
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A dosage form comprises an active ingredient and a confectionery composition. In one embodiment the relative standard deviation of the weight of the dosage form is less than 1%, and the dosage form has at least one face. In another embodiment, a dosage form comprising an active ingredient and a confectionery composition wherein the dosage form has at least one face, does not have a free formed surface, and has a mean polarized light transmission at the angle of maximum extinction which is not greater than the mean polarized light transmission of the dosage form at the angle of maximum transmission. The active ingredient may be a pharmaceutically active agent.

Claims

exact text as granted — not AI-modified
1 . A dosage form comprising at least one active ingredient and a confectionery composition wherein the relative standard deviation of the weight of the dosage form is less than 1%, and the dosage form has at least one face.  
     
     
         2 . A dosage form comprising at least one active ingredient and a confectionery composition wherein the dosage form has at least one face, does not have a free formed surface, and has a mean polarized light transmission at the angle of maximum extinction which is not greater than the mean polarized light transmission of the dosage form at the angle of maximum transmission.  
     
     
         3 . The dosage form of  claim 2 , in which the relative standard deviation of the weight of the dosage form is less than 1%.  
     
     
         4 . The dosage form of  claim 1 , in which the relative standard deviation of the weight of the dosage form is less than 0.5%.  
     
     
         5 . The dosage form of  claim 1 , in which the confectionery composition comprises at least one component selected from the group consisting of fat, amorphous sugar glass and fondant.  
     
     
         6 . The dosage form of  claim 1 , in which the confectionery composition does not contain a gelatin based composition.  
     
     
         7 . The dosage form of  claim 1 , in which the confectionery composition does not contain a gel based composition.  
     
     
         8 . The dosage form of  claim 1 , in which the confectionery composition comprises an amorphous sugar glass component and the dosage form does not have a free formed surface.  
     
     
         9 . The dosage form of  claim 1 , in which all the faces of the dosage form have a surface gloss of about 200-300 gloss units.  
     
     
         10 . The dosage form of  claim 1 , in which the dosage form has two or more faces, and the difference in surface gloss between any two faces is not more than about 20 gloss units.  
     
     
         11 . The dosage form of  claim 10  in which the difference in surface gloss between any two faces is not more than about 15 gloss units.  
     
     
         12 . The dosage form of  claim 10  in which the difference in surface gloss between any two faces is not more than about 10 gloss units.  
     
     
         13 . The dosage form of  claim 1  in which the dosage form has a mean polarized light transmission at the angle of maximum extinction which is not greater than the mean polarized light transmission of the dosage form at the angle of maximum transmission.  
     
     
         14 . The dosage form of  claim 1 , in which the dosage form has a mean polarized light transmission between about 0 to 40 grayscale units at the angle of maximum extinction.  
     
     
         15 . The dosage form of  claim 1  in which the confectionery composition comprises an amorphous sugar glass component and the dosage form does not have a free formed surface.  
     
     
         16 . The dosage form of  claim 1  in which the active ingredient is a pharmaceutically active ingredient.  
     
     
         17 . The dosage form of  claim 1 , in which the dosage form comprises particles which comprise the active ingredient.  
     
     
         18 . The dosage form of  claim 17 , in which the particles have an average particle size of about 50 to about 2000 microns.  
     
     
         19 . The dosage form of  claim 17 , in which at least a portion of the particles are coated particles.  
     
     
         20 . The dosage form of claim, in which the dosage form is a unitary object.  
     
     
         21 . The dosage form of  claim 1 , in which the dosage form does not contain any seams on its surface.  
     
     
         22 . The dosage form of  claim 1  in which the confectionery composition comprises an amorphous sugar glass component.  
     
     
         23 . The dosage form of  claim 1 , in which the dosage form is substantially free of pores having a diameter of 0.5 to 5.0 microns.

Join the waitlist — get patent alerts

Track US2005019376A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.